The impact of primary diseases is substantial, demanding advanced therapeutic modalities. Regenerative therapies represent a especially hopeful avenue, offering the potential to restore damaged parenchymal tissue and alleviate clinical outcomes. Currently, research focuses on several approaches, including the introduction of adult cellular entities